Géczi Lajos and Bodoky György and Rokszin György and Bajcsayné Fábián Ibolya and Torday László:
Survival Benefits of Second-line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma.
PATHOLOGY AND ONCOLOGY RESEARCH, 26 (4).
pp. 2201-2207.
ISSN 1219-4956
(2020)
Preview |
Text
geczi-2020-sunitinib-NHIF.pdf - Published Version Download (292kB) | Preview |
| Item Type: | Journal Article |
|---|---|
| Journal or Publication Title: | PATHOLOGY AND ONCOLOGY RESEARCH |
| Date: | 2020 |
| Volume: | 26 |
| Number: | 4 |
| Page Range: | pp. 2201-2207 |
| ISSN: | 1219-4956 |
| Faculty/Unit: | Faculty of Medicine |
| Institution: | Szegedi Tudományegyetem |
| Language: | English |
| MTMT rekordazonosító: | 31287337 |
| DOI azonosító: | https://doi.org/10.1007/s12253-020-00809-z |
| Date Deposited: | 2020. Oct. 13. 08:26 |
| Last Modified: | 2020. Oct. 13. 08:26 |
| URI: | http://publicatio.bibl.u-szeged.hu/id/eprint/19706 |
| Web of Science® Times Cited: 7 | View citing articles in Web of Science® |
Actions (login required)
 |
View Item |
Download Statistics
Download Statistics
